Skip to main content
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery

Table 2 Platelet number and indices (measured at admission, day 2, and day 7), as well as univariate and multivariate analysis based on 12-month survival status

From: The day after intracerebral hemorrhage: platelet mass index as predictor of survival—a retrospective cohort study

  

12-month survival

   

Parameters

Mean ± SD†;

N (%)‡

Yes (n = 29)

No (n = 30)

P-value

P-value (Adjusted)⁋

P-value (Adjusted)§

PMI (fL/mL)

      

 Admission

2.36 ± 0.77

2.47 ± 0.90

2.25 ± 0.62

0.279

0.048

0.071

 Day 2

2.40 ± 0.67

2.61 ± 0.65

2.18 ± 0.63

0.020

0.004

0.006

 Day 7

3.00 ± 0.90

3.06 ± 0.83

2.93 ± 1.00

0.636

0.332

0.367

PLT (109/L)

      

 Admission

222 ± 75

234 ± 87

211 ± 60

0.231

0.069

0.105

 Day 2

223 ± 65

243 ± 62

202 ± 61

0.017

0.008

0.012

 Day 7

274 ± 94

277 ± 90

271 ± 100

0.819

0.460

0.580

MPV (fL)

      

 Admission

10.7 ± 1.0

10.6 ± 0.9

10.8 ± 1.0

0.657

0.713

0.811

 Day 2

10.8 ± 1.0

10.6 ± 0.9

10.9 ± 1.0

0.184

0.692

0.782

 Day 7

11.0 ± 1.0

11.0 ± 1.0

11.0 ± 1.1

0.975

0.800

0.850

PDW (fL)

      

 Admission

13.2 ± 2.5

13.0 ± 2.6

13.3 ± 2.4

0.734

0.606

0.692

 Day 2

13.2 ± 2.2

12.8 ± 1.9

13.6 ± 2.3

0.166

0.550

0.597

 Day 7

13.6 ± 2.3

13.3 ± 1.7

13.9 ± 2.8

0.385

0.497

0.725

P-LCR (%)

      

 Admission

30.6 ± 8.0

29.9 ± 7.7

31.2 ± 8.3

0.538

0.720

0.820

 Day 2

31.3 ± 7.6

29.8 ± 7.1

32.8 ± 8.0

0.166

0.661

0.760

 Day 7

32.0 ± 7.3

31.4 ± 6.5

32.7 ± 8.4

0.548

0.741

0.935

  1. Bold vaues correspond to statistcally significant p-values
  2. SD Standard Deviation
  3. †For scale variables
  4. ‡For nominal variables
  5. ⁋For age, diabetes, hypertension, Hb, and sPO2 using Repeated Measures GLM
  6. §For age, diabetes, hypertension, dyslipidemia, Hb, glucose, sPO2, lactates, and temperature, using Repeated Measures GLM
Back to article page